GlassScriptPhysician profile
London C Guidry
NPI 1841461514
$24,658.46
in general payments reported to CMS, 2019-2025
31 companies · $1,206 in 2025
The $1,206 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $3,947 · 2021: $845 · 2022: $2,348 · 2023: $1,548 · 2024: $1,107 · 2025: $1,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,860.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $14,695.61 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $1,877.13 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin, Gore Tag Thoracic Endoprosthesis |
| Endologix LLC | $1,557.23 | 2020-2025 | Endocross Device, Torus Stent Graft System |
| Bard Peripheral Vascular, INC. | $1,411.85 | 2019-2022 | |
| Inari Medical, INC. | $787.95 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $741.75 | 2021-2025 | Indigo System, Smart Coil, Penumbra System |
| Shockwave Medical, INC | $487.48 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $376.31 | 2019-2025 | Eluvia, Enroute Transcarotid Neuroprotection System, General - Vascular Intervention |
| Silk Road Medical, INC. | $366.10 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $356.45 | 2019-2025 | Zilver Ptx, Cook Celect |
| Kerecis Limited | $314.00 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $200.01 | 2019-2021 | |
| Avinger INC. | $191.64 | 2019-2020 | |
| Cardiovascular Systems INC. | $179.79 | 2022-2023 | Diamondback Coronary |
| Janssen Pharmaceuticals, INC | $157.64 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $148.74 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Fresenius USA Marketing, INC. | $133.09 | 2020-2024 | Velphoro |
| Terumo Medical Corporation | $127.76 | 2023 | Azur Cx Detachable |
| Surmodics, INC. | $93.89 | 2022 | |
| Ethicon US, LLC | $88.74 | 2020-2025 | Vistaseal |
| Angiodynamics, INC. | $87.69 | 2022 | |
| Medtronic, INC. | $82.70 | 2021-2024 | Endurant Iis, Chameleon |
| Ekos Corporation | $51.63 | 2019 | |
| Laminate Medical Technologies INC. | $23.20 | 2025 | Vasq |
| Lemaitre Vascular, INC. | $21.61 | 2019 | |
| Argon Medical Devices, INC. | $20.93 | 2025 | Clot Management |
| Bolton Medical INC | $20.89 | 2019 | |
| Abbott Laboratories | $15.30 | 2024 | Proclaim |
| Pfizer INC. | $14.19 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.93 | 2019 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw London Guidry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.